POET Technologies: A 14% Rally Masks Class-Action Fears and a Daunting Production Challenge
12.06.2026 - 18:17:03 | boerse-global.de
POET Technologies shares staged a dramatic recovery on Friday, surging more than 14% to €11.12, even as the optical-interconnect specialist confronts a growing legal offensive and questions over its ability to scale production. The jump stands in stark contrast to the stock’s recent slide — it had closed at €9.74 just a day earlier, bringing it roughly 50% below its May peak.
The rally appears to have brushed aside a coordinated push by US law firms seeking shareholders for class actions. Firms including DJS Law Group and The Schall Law Firm have set a June 29 deadline for investors to join a lawsuit alleging that POET misled the market on two fronts: its tax status as a passive foreign investment company and an alleged confidentiality breach by CFO Thomas Mika in a public interview. The legal headache is compounded by an operational setback: Marvell Semiconductor canceled all orders with POET’s Celestial AI subsidiary in April, citing unauthorized disclosures of supply information.
That blow came as the company reported first-quarter revenue of just $503,000 against a net loss of $12.3 million and negative operating cash flow of $8.8 million. Yet the bullish narrative centers on a blockbuster deal with Lumilens announced in May. The agreement includes an initial $50 million order and a potential $500 million in long-term purchases — but only if POET successfully develops the required optical modules and ramps mass production. First samples are not expected until late 2026, with volume production slated for 2027.
Should investors sell immediately? Or is it worth buying POET Technologies?
To bridge that gap, POET raised roughly $400 million in an equity offering in May, which management plans to use to decuple production capacity. The expansion is focused on a Malaysian assembly plant where the company employs over 115 people globally. The cash buffer provides a cushion, but also raises the bar on execution. Since hitting a 52-week high of €18.84 in May, the stock has been on a roller coaster. It remains about 41% below that peak, and the 30-day performance shows a 21% decline — a stark contrast to the 174% gain over the past twelve months.
Investors now face a binary scenario: either the Lumilens deal materializes and transforms the company’s revenue profile, or the legal and operational headwinds deepen. The June 29 class-action registration deadline will provide an early gauge of shareholder sentiment, but the real verdict will depend on POET’s ability to deliver optical modules at scale — and in time to justify the $400 million bet on its Malaysian production line.
Ad
POET Technologies Stock: New Analysis - 12 June
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
